Precigen Statistics
Total Valuation
Precigen has a market cap or net worth of $401.35 million. The enterprise value is $363.29 million.
| Market Cap | 401.35M |
| Enterprise Value | 363.29M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, before market open.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Precigen has 252.42 million shares outstanding. The number of shares has increased by 8.46% in one year.
| Shares Outstanding | 252.42M |
| Shares Change (YoY) | +8.46% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 11.49% |
| Owned by Institutions (%) | 61.68% |
| Float | 130.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 9.14 |
| PS Ratio | 73.79 |
| Forward PS | 18.88 |
| PB Ratio | 4.14 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 66.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.72 |
| Quick Ratio | 1.60 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -665.71 |
Financial Efficiency
Return on equity (ROE) is -73.20% and return on invested capital (ROIC) is -97.08%.
| Return on Equity (ROE) | -73.20% |
| Return on Assets (ROA) | -56.70% |
| Return on Capital (ROIC) | -97.08% |
| Revenue Per Employee | $26,926 |
| Profits Per Employee | -$479,743 |
| Employee Count | 202 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -432,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.77% in the last 52 weeks. The beta is 1.73, so Precigen's price volatility has been higher than the market average.
| Beta (5Y) | 1.73 |
| 52-Week Price Change | +12.77% |
| 50-Day Moving Average | 1.53 |
| 200-Day Moving Average | 1.37 |
| Relative Strength Index (RSI) | 49.84 |
| Average Volume (20 Days) | 916,126 |
Short Selling Information
The latest short interest is 13.16 million, so 5.21% of the outstanding shares have been sold short.
| Short Interest | 13.16M |
| Short Previous Month | 13.05M |
| Short % of Shares Out | 5.21% |
| Short % of Float | 10.08% |
| Short Ratio (days to cover) | 12.72 |
Income Statement
In the last 12 months, Precigen had revenue of $5.44 million and -$96.91 million in losses. Loss per share was -$0.39.
| Revenue | 5.44M |
| Gross Profit | -228,000 |
| Operating Income | -100.69M |
| Pretax Income | -97.34M |
| Net Income | -96.91M |
| EBITDA | -90.64M |
| EBIT | -97.19M |
| Loss Per Share | -$0.39 |
Balance Sheet
The company has $44.76 million in cash and $6.71 million in debt, giving a net cash position of $38.05 million or $0.15 per share.
| Cash & Cash Equivalents | 44.76M |
| Total Debt | 6.71M |
| Net Cash | 38.05M |
| Net Cash Per Share | $0.15 |
| Equity (Book Value) | 97.02M |
| Book Value Per Share | 0.38 |
| Working Capital | 20.77M |
Cash Flow
In the last 12 months, operating cash flow was -$62.63 million and capital expenditures -$5.63 million, giving a free cash flow of -$68.26 million.
| Operating Cash Flow | -62.63M |
| Capital Expenditures | -5.63M |
| Free Cash Flow | -68.26M |
| FCF Per Share | -$0.27 |
Margins
Gross margin is -4.19%, with operating and profit margins of -1,851.28% and -1,781.72%.
| Gross Margin | -4.19% |
| Operating Margin | -1,851.28% |
| Pretax Margin | -1,789.67% |
| Profit Margin | -1,781.72% |
| EBITDA Margin | -1,666.52% |
| EBIT Margin | -1,786.98% |
| FCF Margin | -1,255.08% |
Dividends & Yields
Precigen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.46% |
| Shareholder Yield | -8.46% |
| Earnings Yield | -24.15% |
| FCF Yield | -17.01% |
Analyst Forecast
The average price target for Precigen is $10.00, which is 528.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.00 |
| Price Target Difference | 528.93% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 144.59% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Precigen has an Altman Z-Score of -16.43 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.43 |
| Piotroski F-Score | 2 |